AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
Go back to AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs| ALLIANCEBERNSTEIN HOLDING, L.P. (NYSE: AB) | Delayed: 37.15 -0.19 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.34 | 52 Week High | $26.24 | |||
| Open | $37.01 | 52 Week Low | $16.11 | |||
| Day High | $37.18 | P/E | 21.85 | |||
| Day Low | $36.80 | EPS | $1.70 | |||
| Volume | 248,298 | |||||
